Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results
Go back to Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 245.13 +1.42 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.71 | 52 Week High | $160.00 | |||
| Open | $244.00 | 52 Week Low | $95.80 | |||
| Day High | $248.07 | P/E | 45.56 | |||
| Day Low | $243.81 | EPS | $5.38 | |||
| Volume | 34,616 | |||||

